Despite legislative efforts to restrict private equity practices in health care, bills have stalled in state legislatures and Congress. The collapse of Steward Health Care highlights the ongoing influence of private equity, with regulators approving the sale of Steward’s physicians group to another private equity firm. Lawmakers continue to push for stronger regulatory tools to scrutinize health care buyouts and practices.
Here’s what you need to know:
- Legislative Efforts: Lawmakers have filed bills to restrict private equity practices in health care, but these measures have stalled in both state legislatures and Congress.
- Steward Health Care Collapse: Steward Health Care, backed by a private equity firm, collapsed into bankruptcy, affecting thousands of jobs and patient care.
- Private Equity Buyouts: Despite the collapse, regulators approved the sale of Steward’s national physicians group to another private equity firm, highlighting the ongoing influence of private equity in health care.
- Regulatory Challenges: There is a call for stronger regulatory tools to scrutinize health care buyouts and practices such as sale-leasebacks and dividend recapitalization.
- Industry Defense: Private equity representatives argue that their role in health care is limited and that they provide necessary capital for American companies.
- Future Legislation: Lawmakers continue to push for new laws to prevent private equity firms from stripping assets from health care providers and to ensure better oversight.
The increasing presence of private equity in the healthcare sector has sparked significant debate and regulatory scrutiny. Progressives in Congress, such as Senator Elizabeth Warren and Representative Pramila Jayapal, have led the charge in advocating for greater transparency and accountability in private equity deals. Their efforts have included pushing for legislation that would require more disclosure and oversight of private equity activities in healthcare.
State-level initiatives have also emerged, with lawmakers in California, Connecticut, Massachusetts, Minnesota, Oregon, and Washington introducing bills aimed at regulating private equity investments in healthcare. These measures have faced opposition from the private equity industry, which argues that their investments are essential for modernizing the healthcare sector and improving patient care.
The influence of private equity lobbying has made it challenging to enact meaningful regulations. Recent setbacks, such as Governor Gavin Newsom’s veto of a bill in California, underscore the difficulties in curbing the power of private equity in healthcare. As the debate continues, the future of private equity in healthcare remains uncertain, with both proponents and opponents vying for influence over policy decisions.
Sources and related content
Leave a Reply